The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin

Tascioglu F., Colak O., Armagan O., Alatas O., Oner C.

RHEUMATOLOGY INTERNATIONAL, cilt.26, sa.1, ss.21-29, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 1
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1007/s00296-004-0496-3
  • Dergi Adı: RHEUMATOLOGY INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.21-29
  • Anahtar Kelimeler: glucocorticoids, osteoporosis, rheumatoid arthritis, BONE-MINERAL DENSITY, POSTMENOPAUSAL WOMEN, VERTEBRAL FRACTURE, DOUBLE-BLIND, CORTICOSTEROID-THERAPY, PREVENTION, MASS, HIP, METABOLISM, MARKERS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

The purpose of this study was to assess the effects of alendronate and intranasal salmon calcitonin (sCT) treatments on bone mineral density and bone turnover in postmenopausal osteoporotic women with rheumatoid arthritis (RA) receiving low-dose glucocorticoids.